A bacteriocin-based treatment option for Staphylococcus haemolyticus biofilms
Abstract Bacteriocins are ribosomally-synthesized antimicrobial peptides, showing great potential as novel treatment options for multidrug-resistant pathogens. In this study, we designed a novel hybrid bacteriocin, Hybrid 1 (H1), by combing the N-terminal part and the C-terminal part of the related...
Enregistré dans:
Auteurs principaux: | Christian Kranjec, Sofie S. Kristensen, Karolina T. Bartkiewicz, Mikkel Brønner, Jorunn P. Cavanagh, Aparna Srikantam, Geir Mathiesen, Dzung B. Diep |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4bb49ca80ceb456895b33b7ca266dcc3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Pathogenesis of Staphylococcus haemolyticus on primary human skin fibroblast cells
par: Hala O. Eltwisy, et autres
Publié: (2020) -
The Non-Lantibiotic Bacteriocin Garvicin Q Targets Man-PTS in a Broad Spectrum of Sensitive Bacterial Genera
par: Aleksandra Tymoszewska, et autres
Publié: (2017) -
Distribution of Staphylococcus haemolyticus as the most dominant species among Staphylococcal infections at the Zainoel Abidin Hospital in Aceh, Indonesia
par: SUHARTONO, et autres
Publié: (2019) -
Comprehensive analysis of bacteriocins in Streptococcus mutans
par: Atsuko Watanabe, et autres
Publié: (2021) -
Bacteriocin-mediated inhibition of some common pathogens by wild and mutant Lactobacillus species and in vitro amplification of bacteriocin encoding genes
par: Arooj Ahsan, et autres
Publié: (2021)